Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Gram and colleagues describe valid concerns arising from the growing market for medical direct-to-consumer (DTC) tests but do ...

An emerging field of genetics promises to let parents choose the “healthiest” baby.

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs.

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

“At AEON Clinic, we bridge the gap between science and health. Genomic insights allow us to address health risks at their ...

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa ...